Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acetaminophen Overdose Risk Persists Despite Label Changes – Study

This article was originally published in The Tan Sheet

Executive Summary

Many consumers do not closely read OTC painkiller labels and often do not adhere to package or label instructions, researchers say. Many likely are unaware of or ignore label changes industry voluntarily made and FDA ordered to reduce the risk of liver toxicity due to unintentional overdose.

Advertisement

Related Content

‘Double Check’ Acetaminophen Message Reaches Walmart Pharmacies
Extra Strength Tylenol Cap Warning Prompts Label Reading
Extra Strength Tylenol Cap Warning Prompts Label Reading
P&G Launches ZzzQuil To Enter OTC Sleep Aid Category
Campaign Targets Unsupervised Pediatric Drug Ingestion
McNeil Lowers Recommended Maximum Dose For Extra Strength Tylenol
Acetaminophen Awareness Coalition Prepares To Launch Education Campaign
FDA Launches Safe Use Initiative; Details TBA Following Stakeholder Input
Lower Acetaminophen Doses Recommended Despite Cost Impact, Lack Of Data
FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel